Aviragen Therapeutics IncAdd to My Watchlist

AVIR:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 0.62
    Last
  • 0.04  6.97%
    Today's Change
  • 0.58
    Previous Close
  • Today
     
    0.43
    2.00
    52 Week Low - High
8:10 pm ET 6/27/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding39 million
Market Cap$24 million
Return on Equity ttm--
Last Dividend$6.65
Dividend Yield ttm--
Relative Dividend Yield benchmark--
Dividend Ex-Date11/9/12
Dividend Pay Date11/8/12
Earnings
EPS: Year Actual ttm--
EPS: Year Est. 6/17 ttm-0.760
 
EPS: Quarterly Actual 3/17 -0.11
EPS: Quarterly Est. 6/17 -0.19
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-22.22
Company Description
Aviragen Therapeutics, Inc. provides drugs discovery and development services. The Company offers oral treatment, respiratory syncytial virus prevention, and clinical development services. Aviragen Therapeutics markets its products in the United States.
Revenue$9 million
Net Income$-25 million
Total Assets$73 million
Employees21
Web Sitewww.biotapharma.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!